321 related articles for article (PubMed ID: 19011242)
1. Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin.
Chen M; Sinha M; Luxon BA; Bresnick AR; O'Connor KL
J Biol Chem; 2009 Jan; 284(3):1484-94. PubMed ID: 19011242
[TBL] [Abstract][Full Text] [Related]
2. Integrin (alpha6beta4) signals through Src to increase expression of S100A4, a metastasis-promoting factor: implications for cancer cell invasion.
Kim TH; Kim HI; Soung YH; Shaw LA; Chung J
Mol Cancer Res; 2009 Oct; 7(10):1605-12. PubMed ID: 19808905
[TBL] [Abstract][Full Text] [Related]
3. Integrin alpha6beta4 promotes expression of autotaxin/ENPP2 autocrine motility factor in breast carcinoma cells.
Chen M; O'Connor KL
Oncogene; 2005 Jul; 24(32):5125-30. PubMed ID: 15897878
[TBL] [Abstract][Full Text] [Related]
4. Src kinase pathway is involved in NFAT5-mediated S100A4 induction by hyperosmotic stress in colon cancer cells.
Chen M; Sastry SK; O'Connor KL
Am J Physiol Cell Physiol; 2011 May; 300(5):C1155-63. PubMed ID: 21289293
[TBL] [Abstract][Full Text] [Related]
5. Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.
Radestock Y; Hoang-Vu C; Hombach-Klonisch S
Breast Cancer Res; 2008; 10(4):R71. PubMed ID: 18718015
[TBL] [Abstract][Full Text] [Related]
6. Nuclear factor of activated T cells 5 maintained by Hotair suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis.
Li JT; Wang LF; Zhao YL; Yang T; Li W; Zhao J; Yu F; Wang L; Meng YL; Liu NN; Zhu XS; Gao CF; Jia LT; Yang AG
Breast Cancer Res; 2014 Oct; 16(5):454. PubMed ID: 25311085
[TBL] [Abstract][Full Text] [Related]
7. Ras stimulation of E2F activity and a consequent E2F regulation of integrin alpha6beta4 promote the invasion of breast carcinoma cells.
Yoon SO; Shin S; Mercurio AM
Cancer Res; 2006 Jun; 66(12):6288-95. PubMed ID: 16778205
[TBL] [Abstract][Full Text] [Related]
8. CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway.
Chen PS; Wang MY; Wu SN; Su JL; Hong CC; Chuang SE; Chen MW; Hua KT; Wu YL; Cha ST; Babu MS; Chen CN; Lee PH; Chang KJ; Kuo ML
J Cell Sci; 2007 Jun; 120(Pt 12):2053-65. PubMed ID: 17550972
[TBL] [Abstract][Full Text] [Related]
9. The alpha6beta4 integrin maintains the survival of human breast carcinoma cells in vivo.
Lipscomb EA; Simpson KJ; Lyle SR; Ring JE; Dugan AS; Mercurio AM
Cancer Res; 2005 Dec; 65(23):10970-6. PubMed ID: 16322245
[TBL] [Abstract][Full Text] [Related]
10. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway.
Zhang K; Zhang M; Zhao H; Yan B; Zhang D; Liang J
Dis Esophagus; 2012; 25(8):731-9. PubMed ID: 22458600
[TBL] [Abstract][Full Text] [Related]
11. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
Wang L; Wang X; Liang Y; Diao X; Chen Q
Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylation-induced expression of S100A4 increases the invasiveness of laryngeal squamous cell carcinoma.
Liu J; Guo Y; Fu S; Yang M; Sun KL; Fu WN
Oncol Rep; 2010 Apr; 23(4):1101-7. PubMed ID: 20204297
[TBL] [Abstract][Full Text] [Related]
13. S100A4 hypomethylation affects epithelial-mesenchymal transition partially induced by LMP2A in nasopharyngeal carcinoma.
Lin Z; Deng L; Ji J; Cheng C; Wan X; Jiang R; Tang J; Zhuo H; Sun B; Chen Y
Mol Carcinog; 2016 Oct; 55(10):1467-76. PubMed ID: 26292668
[TBL] [Abstract][Full Text] [Related]
14. PTH-related protein upregulates integrin alpha6beta4 expression and activates Akt in breast cancer cells.
Shen X; Falzon M
Exp Cell Res; 2006 Nov; 312(19):3822-34. PubMed ID: 16965770
[TBL] [Abstract][Full Text] [Related]
15. Use of RNA interference to inhibit integrin (alpha6beta4)-mediated invasion and migration of breast carcinoma cells.
Lipscomb EA; Dugan AS; Rabinovitz I; Mercurio AM
Clin Exp Metastasis; 2003; 20(6):569-76. PubMed ID: 14598892
[TBL] [Abstract][Full Text] [Related]
16. Integrin α6β4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF).
Carpenter BL; Chen M; Knifley T; Davis KA; Harrison SMW; Stewart RL; O'Connor KL
J Biol Chem; 2015 Nov; 290(45):27228-27238. PubMed ID: 26381405
[TBL] [Abstract][Full Text] [Related]
17. Blocking TGF-β inhibits breast cancer cell invasiveness via ERK/S100A4 signal.
Wang XG; Meng Q; Qi FM; Yang QF
Eur Rev Med Pharmacol Sci; 2014; 18(24):3844-53. PubMed ID: 25555875
[TBL] [Abstract][Full Text] [Related]
18. RNA interference targeting against S100A4 suppresses cell growth and motility and induces apoptosis in human pancreatic cancer cells.
Tabata T; Tsukamoto N; Fooladi AA; Yamanaka S; Furukawa T; Ishida M; Sato D; Gu Z; Nagase H; Egawa S; Sunamura M; Horii A
Biochem Biophys Res Commun; 2009 Dec; 390(3):475-80. PubMed ID: 19799859
[TBL] [Abstract][Full Text] [Related]
19. The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells.
Liu S; Li L; Zhang Y; Zhang Y; Zhao Y; You X; Lin Z; Zhang X; Ye L
J Biol Chem; 2012 Aug; 287(36):30228-39. PubMed ID: 22740693
[TBL] [Abstract][Full Text] [Related]
20. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
Zhang J; Zhang DL; Jiao XL; Dong Q
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
